Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival, clinical, and genetic findings in paediatric cardiomyopathy: a five-year prospective study from Brazil.

Cardiology in the young·2025
Same author

Genotype-Phenotype Correlations of Nance-Horan Syndrome in Male and Female Carriers of a Novel Variant.

Genes·2025
Same author

Genotypic-Phenotypic Correlations of Hereditary Hyperferritinemia-Cataract Syndrome: Case Series of Three Brazilian Families.

International journal of molecular sciences·2023
Same author

<i>MYH7</i> p.Glu903Gln Is a Pathogenic Variant Associated With Hypertrophic Cardiomyopathy.

Circulation. Genomic and precision medicine·2021
Same author

BK<sub>Ca</sub> Channel Activation Attenuates the Pathophysiological Progression of Monocrotaline-Induced Pulmonary Arterial Hypertension in Wistar Rats.

Cardiovascular drugs and therapy·2020
Same author

Progression of heart failure is attenuated by antioxidant therapy with N-acetylcysteine in myocardial infarcted female rats.

Molecular biology reports·2020
Same journal

Redefining the Entamoeba landscape with next-generation sequencing: Implications for diagnosis and epidemiology.

Advances in parasitology·2026
Same journal

Parasite-associated microbiomes: An unseen microenvironment.

Advances in parasitology·2026
Same journal

Current status of -omics research in platyhelminth parasites of teleost fish.

Advances in parasitology·2026
Same journal

Key discoveries from research in anisakiasis: From parasite biology to pathology in the human host.

Advances in parasitology·2025
Same journal

Hard to make and hard to take: Exploring the current and future barriers to the development and implementation of antipoverty vaccines in sub-Saharan Africa.

Advances in parasitology·2025
Same journal

Survival of the fittest: How Leishmania evades drug therapy.

Advances in parasitology·2025
See all related articles

Related Experiment Video

Updated: May 30, 2026

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies
07:59

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Cell-based therapy in Chagas disease.

Antonio C Campos de Carvalho1, Adriana B Carvalho, Regina C S Goldenberg

  • 1Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro and National Cardiology Institute, Rio de Janeiro, RJ, Brazil.

Advances in Parasitology
|August 9, 2011
PubMed
Summary
This summary is machine-generated.

Cell-based therapies offer a promising new avenue for treating Chagasic cardiomyopathy, a severe heart condition. These innovative treatments may help regenerate damaged heart tissue and improve the prognosis for affected patients.

More Related Videos

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing &#946;-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

Related Experiment Videos

Last Updated: May 30, 2026

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies
07:59

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing &#946;-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Regenerative Medicine

Background:

  • Chagas disease, a neglected tropical illness, causes cardiomyopathy with a poor prognosis.
  • The underlying mechanisms of chagasic cardiomyopathy are not fully understood.
  • Current treatments for heart failure in Chagas disease are limited to standard therapies.

Purpose of the Study:

  • To review the current knowledge on cell-based therapies for Chagas disease.
  • To explore the potential of cell-based treatments in addressing chagasic cardiomyopathy.
  • To highlight the regenerative and immunomodulatory effects of cell therapies.

Main Methods:

  • Literature review of preclinical and clinical studies on cell-based therapies for Chagas disease.
  • Analysis of studies investigating the mechanisms of cell therapy in the context of Chagas disease.
  • Synthesis of current evidence on the efficacy and safety of cell-based approaches.

Main Results:

  • Cell-based therapies show potential in replacing damaged cardiomyocytes and blood vessels.
  • These therapies may modulate the inflammatory microenvironment perpetuating the disease.
  • Emerging research suggests possible benefits for heart function and disease progression.

Conclusions:

  • Cell-based therapies represent a novel and promising treatment strategy for Chagasic cardiomyopathy.
  • Further research is needed to optimize cell types, delivery methods, and long-term outcomes.
  • These therapies offer hope for improving the management of heart failure in Chagas disease.